Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells

Transfusion

Volumn 49, Issue 2, 2009, Pages 354-361

  Akkök, Çiǧdem A ^a   Holte, Mette R ^b   Tangen, Jon M ^b   Østenstad, Bjørn ^b   Bruserud, Øystein ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CD34 ANTIGEN; CYTARABINE; DIMETHYL SULFOXIDE; ETOPOSIDE; MELPHALAN;

ADULT; AGED; AMYLOIDOSIS; ANGINA PECTORIS; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CARDIOVASCULAR SYMPTOM; CONTROLLED STUDY; CRYOPRESERVATION; ENGRAFTMENT; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; POEMS SYNDROME; SYNCOPE; THROMBOCYTE COUNT;

ADULT; AMYLOIDOSIS; BLOOD PRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKOCYTE COUNT; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEUTROPHILS; PLATELET COUNT; POEMS SYNDROME; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 58949104231     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01949.x     Document Type: Article

References (36)

1. Sauer-Heilborn A, Kadidlo D, McCullough J. Patient care during infusion of hematopoietic progenitor cells. Transfusion 2004 44 : 907 16.
2. Calmels B, Lemarié C, Esterni B, Malugani C, Charbonnier A, Coso D, Schiano de Colella JM, Deconinck E, Caillot D, Viret F, Ladaique P, Lapierre V, Chabannon C. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product. Transfusion 2007 47 : 1268 75.
3. Milone G, Mercurio S, Strano A, Leotta S, Pinto V, Battiato K, Coppoletta S, Murgano P, Farsaci B, Privitera A, Giustolisi R. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age. Cytotherapy 2007 9 : 348 55.
4. Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NK, McCullough J. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991 31 : 521 6.
5. Zambelli A, Poggi G, Da Prada GA, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Preti P, Robustelli Della Cuna G. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998 18 : 4705 8.
6. Halle P, Tournilhac O, Knopinska-Posluszny W, Kanold J, Gembara P, Boiret N, Rapatel C, Berger M, Travade P, Angielski S, Bonhomme J, Deméocq F. Uncontrolled-rate freezing and storage at -80 degrees C, with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 2001 41 : 667 73.
7. Cordoba R, Arrieta R, Kerguelen A, Hernandez-Navarro F. The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product. Bone Marrow Transplant 2007 40 : 1063 7.
8. Kessinger A, Schmit-Pokorny K, Smith D, Armitage J. Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant 1990 5 : 25 7.
9. Alessandrino EP, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L, Klersy C, Martinelli G, Maiocchi M, Pagnucco G, Varettoni M, Perotti C, Bernasconi C. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999 23 : 533 7.
10. Donmez A, Tombuloglu M, Gungor A, Soyer N, Saydam G, Cagirgan A. Clinical side effects during peripheral blood progenitor cell infusion. Transfus Apher Sci 2007 36 : 95 101.
11. Nishihara G, Sakemi T, Ikeda Y, Baba N, Shimamoto Y. Multiple organ failure associated with dimethylsulfoxide and hydroxyethyl starch in autologous blood stem cell transplantation. Nephron 1996 72 : 356 7.
12. Bauwens D, Hantson P, Laterre PF, Michaux L, Latinne D, Tourtchaninoff MD, Cosnard G, Hernalsteen D. Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma 2005 46 : 1671 4.
13. Hentschke S, Hentschke M, Hummel K, Salwender HJ, Braumann D, Stang A. Bilateral thalamic infarction after reinfusion of DMSO-preserved autologous stem-cells. Leuk Lymphoma 2006 47 : 2418 20.
14. Chen-Plotkin AS, Vossel KA, Samuels MA, Chen MH. Encephalopathy, stroke, and myocardial infarction with DMSO use in stem cell transplantation. Neurology 2007 68 : 859 61.
15. Saba N, Sutton DM, Ross HJ, Siu S, Crump RM, Keating A, Stewart AK. High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant. Bone Marrow Transplant 1999 24 : 853 5.
16. Zenhäusern R, Tobler A, Leoncini L, Hess OM, Ferrari P. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol 2000 79 : 523 6.
17. Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant 2000 25 : 1299 301.
18. Cabezudo E, Dalmases C, Ruz M, Sanchez JA, Torrico C, Sola C, Querol S, García J. Leukapheresis components may be cryopreserved at high cell concentrations without additional loss of HPC function. Transfusion 2000 40 : 1223 7.
19. Martin-Henao GA, Torrico C, Azqueta C, Amill B, Querol S, Garcia J. Cryopreservation of hematopoietic progenitor cells from apheresis at high cell concentrations does not impair the hematopoietic recovery after transplantation. Transfusion 2005 45 : 1917 24.
20. Rowley SD, Bensinger WI, Gooley TA, Buckner D. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 1994 83 : 2731 6.
21. Martino M, Morabito F, Messina G, Irrera G, Pucci G, Iacopino P. Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients. Haematologica 1996 81 : 59 61.
22. Curcoy AI, Alcorta I, Estella J, Rives S, Toll T, Tuset E. Cryopreservation of HPCs with high cell concentration in 5-percent DMSO for transplantation to children. Transfusion 2002 42 : 962.
23. Akkök ÇA, Liseth K, Nesthus I, Løkeland T, Tefre K, Bruserud Ø, Abrahamsen JF. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10% DMSO alone give comparable hematopoietic reconstitution after transplantation. Transfusion 2008 48 : 877 83.
24. Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Glück S. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant 2004 10 : 135 41.
25. Lemarie C, Calmels B, Malenfant C, Arneodo V, Blaise D, Viret F, Bouabdallah R, Ladaique P, Viens P, Chabannon C. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate. Transfusion 2005 45 : 737 42.
26. Foïs E, Desmartin M, Benhamida S, Xavier F, Vanneaux V, Rea D, Fermand JP, Arnulf B, Mounier N, Ertault M, Lotz JP, Galicier L, Raffoux L, Benbunan M, Marolleau JP, Larghero J. Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations. Bone Marrow Transplant 2007 40 : 831 5.
27. Lenhoff S, Hjorth M, Westin J, Brinch L, Backstrom B, Carlson K, Christiansen I, Dahl IM, Gimsing P, Hammerström J, Johnsen HE, Juliusson G, Linder O, Melqvist UH, Nesthus I, Nielsen JL, Tangen JM, Turesson I. Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group. Br J Haematol 2006 133 : 389 96.
28. Johnsen HE. Report from a Nordic workshop on CD34+ cell analysis: technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. Nordic Myeloma Study Group Laboratories. J Hematother 1995 4 : 21 8.
29. Calmels B, Houzé P, Hengesse J-C, Ducrot T, Malenfant C, Chabannon C. Preclinical evaluation of an automated closed fluid management device: Cytomate™, for washing out DMSO from hematopoietic stem cell grafts after thawing. Bone Marrow Transplant 2003 31 : 823 8.
30. Nagamura-Inoue T, Shioya M, Sugo M, Cui Y, Takahashi A, Tomita S, Zheng Y, Takada K, Kodo H, Asano S, Takahashi TA. Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adult patients with units shipped from a single cord blood bank. Transfusion 2003 43 : 1285 94.
31. Perotti CG, Del Fante C, Viarengo G, Papa P, Rocchi L, Bergamaschi P, Bellotti L, Marchesi A, Salvaneschi L. A new automated cell washer device for thawed cord blood units. Transfusion 2004 44 : 900 6.
32. Laroche V, McKenna DH, Moroff G, Schierman T, Kadidlo D, McCullough J. Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples. Transfusion 2005 45 : 1909 16.
33. Rodríguez L, Velasco B, García J, Martín-Henao GA. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing. Transfusion 2005 45 : 1391 7.
34. Woo KS, Goh RY, Kim SH, Kwon HC, Kim HJ, Lee YH, Han JY. Number of megakaryocytic progenitors and adhesion molecule expression of stem cells predict platelet engraftment after allogeneic hematopoietic stem cell transplantation. Cytotherapy 2007 9 : 555 61.
35. Kim DH, Jamal N, Saragosa R, Loach D, Wright J, Gupta V, Kuruvilla J, Lipton JH, Minden M, Messner HA. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts. Biol Blood Marrow Transplant 2007 13 : 1233 43.
36. Gold J, Valinski HM, Hanks AN, Ballen KK, Hsieh CC, Becker PS. Adhesion receptor expression by CD34+ cells from peripheral blood or bone marrow grafts: correlation with time to engraftment. Exp Hematol 2006 34 : 680 7.